The slip
PARKINSON RECEIPTno. 4976
21 Oct 2026, 05:16 UTCdopamine neurons, braak
predictionTBC1D7 in dopamine neurons tracks Braak Lewy-body stage
registered0678fe137d95ec1d
discovery+0.04 p=0.910 n=9
replication-0.18 p=0.646 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.04, p 0.910)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT0bc28f8d5fc449cb7b689bbe…
follows 64321e082aec…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4976: TBC1D7 in dopamine neurons, braak
- power
- full sample -0.00 (p 0.990, n 18), 95% CI -0.47 to +0.46. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.00 (p 0.990, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.13 (p 0.615, n 18). could be the mix.
- skeptic
- leave-one-out range -0.13 to +0.12, sign flips 8; without severely affected donors -0.00 (p 0.990, n 18). fragile.
- cell type
- strongest in oligodendrocytes: +0.66 (p 0.0029, n 18) vs -0.00 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TBC1D7 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up TBC1D7 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.02 p 0.929 (needs p < 3.9e-4)